# Ruxolitinib
> **NDA219660** · New Drug Application · Sponsor: APOTEX · Approved 2025-11-21
## Drug
- **FDA Application Number:** NDA219660
- **Application type:** New Drug Application
- **Brand name:** Ruxolitinib
- **Generic name:** Ruxolitinib
- **Active ingredients:** Ruxolitinib
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** None (Tentative Approval)
- **Sponsor:** APOTEX
- **First approval:** 2025-11-21
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=219660)
---
*MORVS · CC0 1.0*